What's Happening?
The National Institute of Animal Biotechnology (NIAB) in Hyderabad is seeking applications for specialized research and technical positions. This recruitment drive is part of a high-impact project led by Dr. Nirmalya Ganguli, focusing on developing an engineered
mammary epithelial cell-based bioreactor for producing human lactoferrin to treat iron deficiency anemia. The project aims to revolutionize the production of human lactoferrin by utilizing engineered mammalian cells as high-efficiency bioreactors. The institute offers a prestigious platform for professionals in the life sciences sector, providing access to cutting-edge infrastructure and opportunities to contribute to innovative therapeutic solutions.
Why It's Important?
This initiative is significant as it addresses the critical issue of iron deficiency anemia, a prevalent health concern. By developing cost-effective therapeutic proteins, NIAB is contributing to the national mission of advancing biomanufacturing capabilities. The project not only enhances the scientific community's understanding of cell engineering but also offers career advancement opportunities for researchers. The recruitment drive supports the development of robust bio-manufacturing platforms, which are essential for producing affordable and effective treatments, thereby potentially improving public health outcomes.
What's Next?
Interested candidates must submit their applications by March 13, 2026. The selection process involves screening suitable candidates, followed by an online walk-in interview for shortlisted applicants. Successful candidates will have the opportunity to work on pilot-scale bioreactor operations and industrial-standard downstream processing, gaining invaluable experience in biopharmaceutical production. This role is ideal for scientists looking to bridge the gap between academic research and industrial biotechnology.
